| View |
|
DRP-1499-14
|
Omeprazole
|
Omzyn IV
|
40 mg
|
Lyophilized Powder for Injection (IV)
|
-
|
Celon Laboratories Private Limited
|
India
|
CLIDP Conversion
|
06 November 2022
|
23 April 2026
|
| View |
|
DRP-10275-07
|
Febuxostat
|
Atenugen
|
40 mg
|
Film-Coated Tablet
|
-
|
Titan Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
06 November 2022
|
06 September 2026
|
| View |
DRP-11746-01_PI_01.pdf
|
DRP-11746-01
|
Paracetamol + Orphenadrine Citrate
|
Mobilan
|
450 mg / 35 mg
|
Tablet
|
Analgesic/ Antipyretic/ Muscle Relaxant
|
Lloyd Laboratories, Inc
|
Philippines
|
Renewal
|
16 February 2024
|
26 February 2029
|
| View |
|
DRP-12012-01
|
Montelukast (as sodium) + Levocetirizine hydrochloride
|
Veltir Plus
|
10 mg / 5 mg
|
Film-Coated Tablet
|
-
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
06 November 2022
|
30 May 2027
|
| View |
|
DRP-11462-02
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Tazonex
|
4 g/500 mg
|
Powder for Injection (I.V.)
|
-
|
Reyoung Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
05 November 2022
|
15 March 2027
|
| View |
|
DRP-655-06
|
Ranitide Hydrochloride
|
MD-CID
|
50 mg/2 mL
|
Sterile Solution for Injection (I.M./I.V.)
|
-
|
Umedica Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 November 2022
|
09 October 2025
|
| View |
|
HRP-226-03
|
Ascorbic Acid
|
Vitzee
|
100 mg/5 mL
|
Syrup
|
Vitamin
|
Drugmaker's Laboratories, Inc
|
Philippines
|
Renewal
|
30 March 2023
|
03 May 2028
|
| View |
|
HRP-229-02
|
Carbocisteine
|
Cisflex
|
50 mg/mL
|
Syrup (Oral Drops) Cherry Vanilla Flavor
|
-
|
Drugmaker's Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
03 November 2022
|
07 December 2027
|
| View |
|
DRP-5684-02
|
Ascorbic Acid
|
Vitzee
|
100 mg/mL
|
Syrup (Oral Drops) Orange Flavor
|
-
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
03 November 2022
|
04 May 2027
|
| View |
|
DRP-8138-02
|
Tobramycin
|
Maxitobra
|
3 mg/mL (0.3% w/v)
|
Ophthalmic Solution (Drops)
|
Anti-infectives
|
Daewoo Pharm. Co., Ltd.
|
Korea
|
Renewal
|
10 June 2024
|
31 October 2029
|
| View |
|
DRP-8929-11
|
Norepinephrine (as bitartrate)
|
Levopha
|
1 mg/mL (4 mg /4 mL)
|
Solution for Injection (I.V.)
|
-
|
BCWorld Pharm. Co. Ltd
|
Korea
|
CLIDP Conversion
|
03 November 2022
|
29 June 2025
|
| View |
|
DRP-11041-02
|
Telmisartan
|
Vicardis
|
40 mg
|
Tablet
|
-
|
Centurion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
03 November 2022
|
12 January 2027
|
| View |
|
DRP-10467-02
|
Rosuvastatin (as calcium)
|
Varostin
|
20 mg
|
Film-Coated Tablet
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
03 November 2022
|
29 September 2026
|
| View |
|
DRP-11398-01
|
Vancomycin
|
Vancomeed
|
500 mg
|
Powder for Injection (I.V.)
|
-
|
Reyoung Pharmaceutical Co. Ltd
|
China
|
CLIDP Conversion
|
02 November 2022
|
08 March 2027
|
| View |
|
DRP-12382-03
|
Sodium Bicarbonate
|
Bicardikon
|
84 mg/mL (8.4% w/v)
|
Solution for Injection (I.V.)
|
Electrolyte Solutions
|
Jeil Pharmaceutical Co., Ltd.
|
Korea
|
CLIDP Conversion
|
03 November 2022
|
29 July 2027
|
| View |
|
DRP-12408-05
|
Cefalexin (as monohydrate)
|
Ceplegen
|
250 mg/5 mL
|
Powder for Suspension
|
-
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
03 November 2022
|
21 July 2027
|
| View |
|
DRP-12412-03
|
Losartan Potassium
|
Genzar
|
50 mg
|
Film-Coated Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
03 November 2022
|
03 August 2025
|
| View |
|
HRP-553
|
Ethyl Alcohol
|
St. Raphael
|
70mL/100mL (70%v/v)
|
Solution
|
Antiseptic/Disinfectant
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
Renewal
|
07 August 2024
|
11 September 2029
|
| View |
|
DRP-12971
|
Propranolol Hydrochloride
|
Indirin
|
40 mg
|
Film-Coated Tablet
|
Beta blocking agents, non-selective
|
Sydenham Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
13 November 2022
|
18 October 2027
|
| View |
|
DRP-12970
|
Propranolol Hydrochloride
|
Indirin
|
10 mg
|
Film-Coated Tablet
|
Beta Blocking Agents, Non-Selective
|
Sydenham Laboratories, Inc.
|
Philippines
|
Initial (Variation)
|
01 August 2023
|
01 August 2028
|